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ScienceDirectHuman genetic studies have long been vastly Eurocentric,
raising a key question about the generalizability of these study
findings to other populations. Because humans originated in
Africa, these populations retain more genetic diversity, and yet
individuals of African descent have been tremendously
underrepresented in genetic studies. The diversity in Africa
affords ample opportunities to improve fine-mapping
resolution for associated loci, discover novel genetic
associations with phenotypes, build more generalizable
genetic risk prediction models, and better understand the
genetic architecture of complex traits and diseases subject to
varying environmental pressures. Thus, it is both ethically and
scientifically imperative that geneticists globally surmount
challenges that have limited progress in African genetic
studies to date. Additionally, African investigators need to be
meaningfully included, as greater inclusivity and enhanced
research capacity afford enormous opportunities to
accelerate genomic discoveries that translate more effectively
to all populations. We review the advantages, challenges, and
examples of genetic architecture studies of complex traits and
diseases in Africa. For example, with greater genetic diversity
comes greater ancestral heterogeneity; this higher level of
understudied diversity can yield novel genetic findings, but
some methods that assume homogeneous population
structure and work well in European populations may work
less well in the presence of greater heterogeneity in African
populations. Consequently, we advocate for methodological
development that will accelerate studies important for all
populations, especially those currently underrepresented in
genetics.
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Historical biases in genetic studies
Nearly a decade ago, 96% of participants in genome-wide
association studies (GWAS) were of European descent
[1]. While European individuals now account for 78% of
GWAS participants [2], the non-European proportion
has stagnated since 2014. African ancestry individuals
constitute merely 2.4% of participants (although notably
account for 7% of all associations) [2]. This participant
bias results in interpretability gaps by ancestry with
medically relevant consequences [3,4]. For example,
while easily avoidable, African American patients were
more likely than white Americans to be incorrectly told
they have a genetic mutation that increases their risk of
hypertrophic cardiomyopathy, an early-onset life-threat-
ening heart disease, at leading genetic testing labs [5].
Additionally, drug metabolism genes such as CYP3A4
contain mutations that can alter dosage requirements,
but pharmacogenetic variants are disproportionately
uncatalogued among African populations [6], so geno-
type-based dosage guidelines are less useful. In the US,
the National Human Genome Research Institute has
prioritized increased diversity in genetic studies [7].
This prioritization is an important step that, if heeded,
will aid interpretations in medical genomics for all eth-
nicities [8]. Greater inclusivity of African populations in
medical genomics is important for accelerating genomic
discoveries, enabling reconstruction of modern human
origins, producing results that can be translated across
populations more accurately, identifying genetic associa-
tions with traits for variants absent elsewhere, and build-
ing research capacity in Africa.
Genetic study biases have not happened in a vacuum, but
have had widespread consequences for GWAS tools andCurrent Opinion in Genetics & Development 2018, 53:113–120
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Map of publicly available African samples and corresponding language
families from previous studies. Reference data comes from several
previous studies [12,15,38,39,83–87].resources in African populations. Genotyping arrays have
traditionally been biased towards alleles most frequent
and imputable in European populations [9,10], com-
pounding biases in which GWAS identify variant associa-
tions most common in the study population [11,12]. In
contrast, array backbones prioritizing SNPs that maxi-
mally tag variants across all populations improve imputa-
tion performance, providing more even genomic coverage
[13]. Perhaps more importantly, imputation panels are
vastly Eurocentric, shortchanging representation of the
greater haplotypic diversity present in Africans from
deeper recombination history [12,14,15]. The most
widely available African sequencing resources have
biased representation towards African Americans and
West Africans [8,12], leaving huge swaths of African
diversity uncatalogued.
Existing challenges to surmount for African
genetics studies
To empower African genetic studies and build capacity
for research aiding biological understanding across a
diverse swath of humanity, we review challenges that
need to be confronted and continually addressed.
Historical
Africa has long been subjected to a violent and oppressive
colonial history that has bred suspicion and an anticipa-
tion of resource exploitation. This understandable mis-
trust continues to strain ongoing relations, with new actors
such as China in addition to European groups scrambling
for African resources [16,17]. The impact on research
collaborations is evident, with some authors discussing
‘neo-colonial science’ [18]. Such strained relations are
more pronounced in collaborations involving genetic
studies, especially when shipping samples out of Africa
and the global south [19]. Some discuss ‘genomic
sovereignty’ of Africans and ownership of African genetic
material [20]. Proponents of international collaborations
argue that working with high income countries will even-
tually ensure equity, justice, and benefit to Africans, with
capacity building for genomic research providing imme-
diate benefit for African institutions [21], although con-
cerns have been raised about the sustainability of these
efforts. Ongoing tensions weigh the benefit to Africans by
including more African researchers and DNA in global
research against the challenges of promoting African
science while integrating and importing the best science
around the world into Africa (Figure 1).
Infrastructural
Conducting genetic studies in Africa is not an easy task.
Infrastructural problems can include unreliable or no
electricity in clinics and laboratories that process samples,
impassable roads in some areas, and crime or political
instability making some areas dangerous and/or inacces-
sible for researchers. Many African countries do not have
sufficient laboratory equipment or facilities for genomicsCurrent Opinion in Genetics & Development 2018, 53:113–120 research, and most require imported reagents. Importing
is not only time-consuming, but also costly—reagents are
often many times more expensive in Africa than Western
countries in real terms, not including shipment costs.
Biobanks are less abundant, partially due to power inter-
ruptions affecting storage and processing of samples.
Some African institutions have experience in large-scale
human genetic analyses; the H3ABionet consortium has
developed core bioinformatics infrastructure in Africa
[22]. However, high-speed internet connections and
powerful computers are not always available to access
large data files. Human resource issues can also be a
challenge, namely high staff turnover due to inadequate
pay, competing demands for time from qualified staff,
and/or too few qualified staff. Relatedly, brain drain is a
major issue, as many skilled African scientists leave the
continent in search of greener pastures [23,24]. To be
sensitive to these challenges, some major international
research initiatives such as H3Africa have required a
relatively long embargo period on publication for African
researchers [25]. Connecting African researchers to ade-
quate computing power (e.g. stable wireless connections
to cloud computing) may offer more direct means to
facilitate research. Compared with the relative ease of
acquiring samples in the global north, the focus of data-
banks on European/white populations is unsurprising, but
it is nonetheless imperative that researchers rise to these
challenges for the benefit of all.
Funding
Genetics research is expensive, and a lack of attention
from African policy makers in resource-limited settings is
primarily driven by competing priorities for more imme-
diate public health concerns, including infectiouswww.sciencedirect.com
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tion is still the most expensive part of genomics, whereas
data analysis is more affordable and therefore a viable
option for capacity building [28]. Furthermore, journals
from the developed world often exist behind expensive
pay-walls that are inaccessible to some researchers and do
not always encourage publication of work from the global
south, often returning manuscripts without review citing a
lack of ‘sufficient general interest’. Having fewer pub-
lications has a knock-on effect on future grant funding
and attracting students.
Nearly all funding for genetics research comes from
outside Africa, raising questions for African scientists
about the utility of investigating disease genetics with
less long-term funding security and intellectual freedom
to prioritize their field of study. Incentives differ from the
West, heavily favoring medicine over research training—
clinical demands are heavier, PhD programs are scarce,
and research often does not pay. However, some external
research funding in genomics, most notably by the
Human Heredity and Health in Africa (H3Africa) Initia-
tive, are being led by African scientists. H3Africa funding
by the NIH (USA) and Wellcome Trust (UK) totals more
than $216 million in 2015 for 185 projects in 28 African
countries [29]. Its aim is to build the capacity for African
scientists to conduct genomic research on heritable dis-
eases afflicting Africans [30,31]. This international sup-
port is essential for African geneticists to continue their
research [21].
Ethical
Ethics review boards may lack familiarity with genomics
research, which creates challenges for advising long-term,
large-scale collaborative genetic studies that can in turn
delay funded projects [28]. These challenges are partially
driven by restrictive ethical guidelines and uncertainty
about the benefits of such studies to African populations
[28]. Unlike in the US, genetics projects are subject to
ethics review both at the provincial and national levels as
a legacy of colonialism, which can lead to years-long
delays. Ethics approval by regulatory bodies in Africa is
mostly restricted to project-specific research questions,
often raising questions around ‘broad consent’ and
‘indefinite storage’ of samples that are not easy to answer.
A primary concern about loss of control and ownership
over the DNA samples arises when they are shipped
abroad [32]. Burgeoning interest in building large-scale
genomics collaborations in Africa has resulted in a recent
best practices ethical framework for genomics research
and biobanking in Africa [25].
Some communities have set up local councils to oversee
research projects and publication of results allowed from
the research [33]. While these are excellent in theory, in
practice there can be long delays, misunderstanding due
to unfamiliarity of lay people with jargon, and a lack ofwww.sciencedirect.com continuity in leadership. Consequently, even when
extensive consultation on planned or existing research
projects has taken place, this often needs to be repeated
at each subsequent visit. New council leaders sometimes
try to enforce sample destruction before allowing further
sampling, even when consent forms specify long sample
storage. A middle ground of continuous community
leadership from members more familiar with research
methodology and terminology that is acceptable to the
council would be ideal, but is often infeasible. Further-
more, while returning scientific discoveries to commu-
nities or participants should be the norm, re-contacting
study participants in communities can be challenging as
people lose cell phones or move for employment
opportunities.
Respect and consent
To ensure mutual respect in collaborative African genet-
ics studies, it is important to avoid generalizing ‘African-
ness’ in such a vast continent, comprising not only more
genetic diversity than the rest of the world, but also many
cultures, language groups, and world views, some of
which are marginalized or discriminated against. Thus,
it is important to obtain perspectives from diverse conti-
nental Africans when communicating science broadly.
Furthermore, meaningful engagement with African col-
leagues is vital to healthy collaborations and to avoid
tokenism. Additionally, obtaining informed consent for
genomics research can be complex in any setting, but
poses more challenges where there are lower income and
literacy levels or language barriers. Furthermore, some
diseases such as mental illness are subject to greater
stigma in some African communities, requiring cultural
awareness and sensitivity to differences. Participants may
misunderstand the study purpose or expect benefits that
are not included, such as better disease treatment [34] or
individual-level ancestry results useful for land claims.
Additionally, in some African societies, decisions to par-
ticipate in research studies are made collectively as well as
at the individual level [35], necessitating consultation
with community leaders.
Communicating science respectfully can be challenging
when nomenclature is subject to sociopolitical debate, as
with the descendants of the original hunter-gatherers of
Southern Africa. In an attempt to be politically correct,
many population geneticists use ‘KhoeSan’ to refer to the
Khoe and San groups collectively. However, the San
Council of Southern Africa prefers to keep these terms
separate (i.e., San and Khoe or Nama) to denote different
cultures. Many ‘San’ individuals prefer being called
‘Bushmen’, while others consider the word to be pejora-
tive. Labels are only useful insofar as they are universally
informative, and respect is imperative. Wide pre-publica-
tion consultation is obviously necessary [36], but com-
plete consensus is unlikely.Current Opinion in Genetics & Development 2018, 53:113–120
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Unlike most of the GWAS and complex trait studies that
have been conducted in Europe, assumptions of homo-
geneous population structure are more likely to be vio-
lated in Africa, as few populations have remained isolated
and unchanged over the past 4000 years [37]. This higher
level of diversity across African populations relative to
others [38,39] creates greater challenges when attempting
to balance case/control collections at the outset of many
studies due to greater complexities in population struc-
ture, including variable LD patterns between study sites.
Consequently, false positives are more likely to arise from
confounding due to unaccounted population stratifica-
tion, especially for rare variants, which are challenging
to analyze [40,41]. Higher rates of genetic diversity also
result in a larger number of effective tests, meaning that
the standard multiple testing threshold of p < 5e-8 needs
to be roughly twice as stringent in African GWAS (p <
2.5e-8) [42]. Additional challenges arise from a dearth of
large, easily accessible reference panels in Africa. While
the African Genome Variation Project and related pro-
jects have worked to ameliorate this gap, data access is
somewhat more challenging and slower than the publicly
available 1000 Genomes Project [15].
Because some complex trait genetics methods assume
homogeneity that is more often violated in African popu-
lations with higher diversity, methodological advance-
ments that explicitly account for structure over a range
of time periods will be especially useful [43]. For exam-
ple, heritability estimates in the presence of admixture
can be biased and inflated [44]. Alternatively, higher
heritability estimates may be driven by higher relatedness
among geographically proximal individuals. The pres-
ence of structure can create challenges disentangling
the heritable component due to genetics versus similar
environments [44]. Other methods for inferring heritabil-
ity (e.g. LD score regression) are suboptimal in the
presence of admixture, as LD from these populations
are often not reflective of the study cohort and vary locally
[45,46]. Other methods for inferring genetic architecture,
including Bayesian linear mixed models (LMMs) such as
the Bayesian sparse LMM (BSLMM), Bayes R, and
BOLT-LMM, have been shown to be effective at con-
trolling population stratification, cryptic relatedness, and
also increase power in structured populations [47,48–50].
These studies demonstrate that more advanced GWAS
methods may be more fruitful generally, but especially in
Africa where higher rates of substructure are typical.
Successful GWAS strategies in African and
African descent populations
Despite these challenges, many successful examples illu-
minate paths forward. Because of high prioritization of
infectious disease studies, most positive examples exist
for genetic susceptibility studies, including of tuberculosis
[51–53], malaria [54], sickle cell disease modifiers [55], HIVCurrent Opinion in Genetics & Development 2018, 53:113–120 [56–59], nontyphoidal Salmonella [60], and trypanosomes
[61]. Significant findings were aided by simpler genetic
architectures and higher genetic risk divergence between
endemic cases versus high-risk controls due to natural
selection. Some challenges of studying these evolutionarily
important traits, however, are high levels of genetic diver-
sity in the parasite and variable LD patterns among popu-
lations, sometimes necessitating specialized association
approaches that allow for multiple independent origins
of resistance loci and/or allelic heterogeneity [54]. Some
anthropometric studies have faced similar challenges and
advantages due to high divergence, natural selection, and
genetic architectures, such as in skin pigmentation
[62,63]. In smaller cohorts that are underpowered for
discovering individual loci, gene-based associations can
sometimes be useful in conjunction with functional follow
up [64]. Studies of traits with elevated prevalence in African
Americans, such as BMI, prostate cancer, and low birth
weight [65–67] have analyzed genome-wide significant loci
by local ancestry and/or more easily fine-mapped variants
with narrower LD. Additionally, multiethnic studies
including African Americans have demonstrated the utility
of integrative genomics approaches for fine-mapping, e.g.
with pulmonary function variants [68]. Several recent
GWAS reviewed here have used linear mixed models, with
a random effect to account for genetic relatedness. These
models are useful but can produce inflated heritability
estimates, which can be corrected using a second random
effect to measure spatial distance as a proxy for environ-
mental effects [69].
Advantages and opportunities for genetic
architecture studies in Africa
The opportunities for large-scale genetic studies in Africa
are ample. Growing inclusion of African Americans in
medical genomics studies is crucial, but still leaves
behind many populations and large swaths of sub-Saharan
African genetic diversity, and these populations may
greatly increase our understanding of complex trait
genetic architecture [70]. There is more genetic and often
phenotypic diversity in Africa that has been understu-
died, meaning there is considerable low-hanging fruit for
novel findings and insights into the genetic architectures
and etiologies of complex traits. More rapid LD decay in
Africa also means there is greater fine-mapping resolution
to pinpoint causal variants influencing traits than will be
discovered in any other global population [71], as
reviewed recently [72]. For example, several variants in
TCF7L2 were associated with type 2 diabetes in Euro-
pean and East Asian populations in the early GWAS era,
but candidate loci were narrowed considerably via com-
parison with more diverse West African cohorts, even
with smaller cohort sizes [73].
Major opportunities also present themselves in precision
medicine. For example, polygenic risk scores have been
of growing interest as large-scale GWAS now offer low-www.sciencedirect.com
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However, these scores generalize poorly across diverse
populations [11]. European GWAS results consistently
predict genetic risk several-fold less accurately in non-
Europeans, performing the worst in African Americans
(and by extension, likely even worse in eastern, central,
and southern African populations) [76–79]. A typical but
somewhat misguided argument in favor of immediate
translational implementation of polygenic risk scores is
that standard clinical lab tests from blood panels are often
differentially informative across ethnicities and more
reliable in European descent populations. However,
interpretability gaps for current clinical tests are less
acutely and consistently worse in non-European popula-
tions than genetic risk prediction; the underlying biology
remains the same, such that for all diseases, drugs do not
routinely work many-fold better in European than Afri-
can-descent populations. Further, new population-spe-
cific interpretation of common clinical lab tests enables
better prognostic value than existing reference intervals
[80]. In contrast, the most significant and highest fre-
quency genetic variants from GWAS used to predict
genetic risk are not likely to be the same across popula-
tions, even when the underlying causal variants are the
same. This is due to GWAS discovery biases, as variants
used to predict risk tend to explain more phenotypic
variation in the study population. While improved ana-
lytical methods hold promise, the only way genetic pre-
diction power of inherited diseases in non-Europeans can
truly be made equal is with massive investments to
produce similar-sized GWAS of these phenotypes in
non-European populations. Additionally, discoveries
based on African genetics contribute to global knowledge,
but many African population groups are sufficiently dif-
ferent [37] that insights made from trans-ethnic studies
can similarly be gained by analyzing multiple GWAS of
different African populations.
As a major genetics mission is to understand the biological
basis and evolutionary origins of diseases and traits and use
this knowledge to perform biologically-informed drug dis-
covery, human evolution tells us that Africa has a huge role to
play. Progress so far has been slower due to a need for
increased capacity and collaborative engagement with Afri-
can investigators. Several outstanding examples of this
potential already exist, such as the Southern African Human
Genome Programme (SAHGP), one of the first genetic
architecture studies of African participants fully funded
and analyzed by Africans [81]. International collaborations
have also blazed the trail for meaningful collaborations with
deep investments in building research capacity in human
genomics, such as MalariaGEN, partnerships by the African
Center of Excellence for Genomics of Infectious Diseases
(ACEGID), as well as the Global Initiative for Neuropsy-
chiatric Genetics Education in Research (GINGER) pro-
gram.Calls fromAfricanresearchers for fundingandbuilding
research capacity in genetics [70,82] should be thoughtfullywww.sciencedirect.com heeded to ensure that those with the greatest public health
needs are not the last to benefit.
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